share_log

D. Boral Capital Initiates Coverage On Context Therapeutics With Buy Rating, Announces Price Target of $9

D. Boral Capital Initiates Coverage On Context Therapeutics With Buy Rating, Announces Price Target of $9

D. Boral Capital发布买入评级的报道,宣布将股价目标定为9美元
Benzinga ·  2024/11/25 20:53  · 评级/大行评级

D. Boral Capital analyst Jason Kolbert initiates coverage on Context Therapeutics (NASDAQ:CNTX) with a Buy rating and announces Price Target of $9.

D. Boral Capital 分析师Jason Kolbert开始覆盖Context Therapeutics (纳斯达克:CNTX),给予买入评级,并宣布目标价格为9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发